Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells - Wikidata - awgldk - TriplyDB

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

http://www.wikidata.org/entity/Q31055456

about

The Role of MicroRNAs in Myeloproliferative Neoplasia MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia miRNAs as Biomarkers in Chronic Myelogenous Leukemia Identification and characterization of microRNAs by high through-put sequencing in mesenchymal stem cells and bone tissue from mice of age-related osteoporosis.Establishing reliable miRNA-cancer association network based on text-mining method.MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.Regulation of cancer metastasis by cell-free miRNAs.A computational approach to identifying gene-microRNA modules in cancer.Long noncoding RNAs in diseases of aging.Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia.miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.Upregulating miR-146a by physcion reverses multidrug resistance in human chronic myelogenous leukemia K562/ADM cells.MicroRNAs as Haematopoiesis Regulators.MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.Role of epigenetics in chronic myeloid leukemia MicroRNAs in myeloid malignancies.Hematological malignancies: role of miRNAs and their in silico aspects.Genetic events other than BCR-ABL1.Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.The Interplay between PP2A and microRNAs in Leukemia.miR-155 effectively induces apoptosis in K562 Philadelphia positive cell line through upregulation of p27kip1.miR-564 is downregulated in gastric carcinoma and targets E2F3.Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer Epigenetic impacts of ascorbate on human metastatic melanoma cells.miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis.Unraveling the determinants of microRNA mediated regulation using a massively parallel reporter assay.Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway.Hairless Up-Regulates Tgf-β2 Expression via Down-Regulation of miR-31 in the Skin of "Hairpoor" (HrHp) Mice.Overexpression of miR-202 re-sensitizes imatinib resistant chronic myeloid leukemia cells through targeting Hexokinase 2 (HK2).Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.

P2860

Q26739435-1E8C0261-53EB-4967-B731-C4DE76A8D9C2 Q26766288-39481083-D3F0-43C2-A13E-D105E5810BC8 Q28087081-C8267B43-86CA-4F95-B938-3D1AAB9F7B2E Q31131903-F0F5BBC3-6D88-4361-934B-1C2CD76DF051 Q33594058-8F7E95CF-B80E-41D3-97E9-4013736695E0 Q33612847-7FFCFF96-C28F-44FC-9F25-083CFFE8EFA9 Q34109784-B842F78C-B74D-4D80-BCA7-D7C511F86C7F Q34599354-4F4988FE-9A65-4C9B-97E7-F38F89EFDABC Q34703835-A42E241B-19CB-478D-94BD-D66EEB21C897 Q35034340-37D0D988-0F9A-4353-B7C7-79498D20C5F3 Q35547227-E74072B4-44CB-427B-BD8A-593A0A38F42E Q36422024-5F37A485-9236-4988-8251-91E13FE80253 Q36835382-C9778A19-CA93-4B6F-A64C-99890DC83D69 Q37236236-6D540BD7-3EF8-4BB1-AFEB-97B28E9C47B6 Q37447892-A0FE88A2-0A4D-453B-8FFA-DED0EFDCF30C Q37448597-35851B20-8ED2-4630-A860-85DCFB32C94F Q37636608-ED449B58-18DF-4EAA-95A4-2E6CEF853D10 Q38072315-08C4BBCF-7B36-4D35-87A4-2A3906147D90 Q38107272-490A7D72-474A-4D3C-A977-79CCDD0A5880 Q38140001-2D4A7249-3AC6-4300-965B-9B5B7347CEC0 Q38177162-2D6E5D50-AF59-4458-B3E4-A3FD23D9AD93 Q38297582-C394BD5F-1F72-4FDB-B129-6EC98F6BFE0E Q38370368-5803CD6E-C868-4A9E-9306-DCB688C7F5F7 Q38696228-1D576617-EF97-4CF9-A70F-73018BE5EE26 Q38739532-334E62A1-75D4-45E8-9316-3A41CB3888BF Q38880958-97CBC152-4546-4A6C-8C29-18116F26CC25 Q39420865-DAD696FF-B631-4C31-951D-FC976EF48178 Q42002131-D052B604-991E-4020-AC13-DBD115714853 Q47158011-50004F62-F607-448C-9D32-03B77F475114 Q48095850-E4FA8126-F863-485F-8841-C1FF6DD26F06 Q48505242-DDF5B576-FFF3-472F-9BE0-CF332734C7B6 Q50603583-947CFD0E-3BED-4DAF-A5C2-B9060F8CDC2D Q52646158-C774FFF2-410C-4C0A-BD08-C3D7F595FEBB Q53561107-6CE1F051-F5B9-4708-A6C9-7CC141311B61 Q54206519-837C37C3-36A3-45DE-A433-8AB11A0BE260

P2860

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

http://www.wikidata.org/entity/Q31055456

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

@ast

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

@en

type

label

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

@ast

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

@en

prefLabel

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

@ast

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

@en

P1433

Q31055456-776388A6-981C-4D3B-B4B8-9C29A8C967A9

P1476

Q31055456-DD2871DB-5AA4-4D8C-ABA8-48D7E0DA2A66

P2093

Q31055456-0238B232-44EE-4102-A72B-CD3345D190C6

Q31055456-3CEEF38E-38F3-470D-B57D-27A92A74E0D9

Q31055456-44222E8A-4F0E-472E-9453-7CF60E7F4A69

Q31055456-53D5CD72-6545-4412-8B5D-508E45FB1986

Q31055456-ACBFC3B5-DFEE-4FC4-8D7A-979A721424FB

Q31055456-ADEFBC30-10E4-438D-8E06-FB8059C881B6

Q31055456-BC508CBD-200D-4CCC-B82B-72AAF28B565A

Q31055456-D4A2346D-73A6-4540-9F5B-B5C5AD0E0FDE

P2860

Q31055456-0137B619-E53A-4C3C-B742-E602744C03DB

Q31055456-09EB2C9F-EDE6-4744-89A8-91480E9271FA

Q31055456-0B2D47CA-EEF1-46A7-8618-C5BB2998CF7E

Q31055456-0D24CE2E-006D-4732-A2AE-90324AD6EC47

Q31055456-132C2F43-77E4-417B-A746-D690708EBD51

Q31055456-1760B435-3A10-479E-9E2A-86D3B67B55B2

Q31055456-186CC32B-7AE8-4528-8A74-62ABD34CFAAC

Q31055456-19D5D1D2-37B1-4EDE-8866-99C4D80A64F6

Q31055456-1D079D2E-8D37-46A0-A9A7-D2E481C7000B

Q31055456-1DB9559E-8E14-46FB-B189-86ECE39B6F89

P304

Q31055456-5918B28C-D814-4CB9-B429-BE92BDF1D51B

P31

Q31055456-2473D868-692A-44E8-982D-93002DEB1AAF

P356

Q31055456-D645D787-6FDA-43CB-939C-29E38D3A2F3C

P407

Q31055456-6B6D26EF-25C1-4D6B-B766-11C3753114FC

P433

Q31055456-D4B05FF6-0258-43B8-BC59-F466142DDB41

P478

Q31055456-07430150-8916-4CAA-9186-2F7B649624B5

P50

Q31055456-ED27695E-1F2B-418A-B9D3-8814C53594BF

P577

Q31055456-4254B9EE-8ED5-4297-9C15-A3E608A41E11

P5875

Q31055456-AA0E0850-4A3C-40FB-9677-57D07221C484

P698

Q31055456-3EE76FAE-02AC-4FC0-82CE-E2ACA669D780

P921

Q31055456-534EDB09-E89E-4E4C-8AE6-CF0CB3F14655

Q31055456-EC1BAABC-037B-428C-9331-B9E51FC72B8D

P932

Q31055456-1B4AB38B-135A-4204-94EE-5DC4D22C031B

P356

JOURNAL.PONE.0035501

P1433

P1476

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

@en

P2093

Adelina Ovcharenko

http://www.w3.org/2001/XMLSchema#string

Amos Toren

http://www.w3.org/2001/XMLSchema#string

Galit Granot

http://www.w3.org/2001/XMLSchema#string

Metsada Pasmanik-Chor

http://www.w3.org/2001/XMLSchema#string

Noam Shomron

http://www.w3.org/2001/XMLSchema#string

Ofer Shpilberg

http://www.w3.org/2001/XMLSchema#string

Oshrat Hershkovitz Rokah

http://www.w3.org/2001/XMLSchema#string

Shira Modai

http://www.w3.org/2001/XMLSchema#string

P2860

Charting the molecular network of the drug target Bcr-Abl

KEGG: kyoto encyclopedia of genes and genomes

miRBase: microRNA sequences, targets and gene nomenclature

A microRNA expression signature of human solid tumors defines cancer gene targets

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas

miRNAs in human cancer

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

P304

e35501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0035501

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Metsada Pasmanik-Chor

P577

2012-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224285285

http://www.w3.org/2001/XMLSchema#string

P698

22511990

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

3325224

http://www.w3.org/2001/XMLSchema#string